Eleven heavily pretreated patients with CD19‐positive cancers, including non‐Hodgkin lymphomas (NHL) and chronic lymphocytic leukaemia (CLL), have been treated with a single infusion of CAR NK cells following lymphodepletion chemotherapy. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.